Endoluminal Solutions Inc.
PrivateLast Round
M&A
Jul 1, 2024
Est. Valuation
$165M
Total Funding Raised
$97.24M
Company Overview
Endoluminal Solutions Inc. is a medical device company that develops innovative, disposable endoscopic systems specialized for gastric cancer screening.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endoluminal Solutions Inc. Comparables
Compare Endoluminal Solutions Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cortex, Inc. | 72% | |
| AI Medical Service Inc. | 72% | |
| Ambu A/S | 69% |
Endoluminal Solutions Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jul 1, 2024 | ||||
| Series I | May 29, 2019 | ||||
| Series E | Nov 25, 2009 | ||||
| Series D | Aug 29, 2007 | ||||
| Series A | Jun 4, 2003 |
Endoluminal Solutions Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Radius Ventures | Series I |
| Evidity Health Capital | Series I |
| Chicago Growth Partners | Series D, Series I |
| MPM BioImpact | Series D, Series A |
| SightLine Partners | Series I |
| Advanced Technology Ventures | Series D, Series E, Series I, Series A |
| Canaan Partners | Series I |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2024
$105M round led by Merit Medical Systems Inc.
- Nov 25, 2009
$22M round led by Advanced Technology Ventures.
Recent news
Latest coverage and updates
- is_developingAug 12, 2026
Following a seed funding round in Feb '26, endoluminal solutions, Inc. is developing a single-use endoscope in Japan designed to reduce patient discomfort and simplify gastric cancer screening.
- is_developingAug 10, 2026
endoluminal solutions, Inc., a University of Osaka spinout in Japan, is developing a slim, lightweight, single-use endoscope designed specifically for gastric cancer screening to reduce patient discomfort and simplify screening; development demonstrates technical feasibility as of Aug '26.
Endoluminal Solutions Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Endoluminal Solutions Inc.'s valuation, stock price, and market status.
Is Endoluminal Solutions Inc. a public or private company?
Endoluminal Solutions Inc. is a private company.
What is the current stock price of Endoluminal Solutions Inc.?
Endoluminal Solutions Inc. is a private company, so its shares have no public market price. Caplight tracks Endoluminal Solutions Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Endoluminal Solutions Inc. worth (valuation)?
Endoluminal Solutions Inc.'s valuation is estimated at $165.0M based on funding round data.
Can I buy Endoluminal Solutions Inc. stock?
Endoluminal Solutions Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Endoluminal Solutions Inc.'s last funding round?
Endoluminal Solutions Inc.'s most recent funding round was M&A on July 1, 2024.
Who are the main investors in Endoluminal Solutions Inc.?
Key investors in Endoluminal Solutions Inc. include Radius Ventures, Evidity Health Capital, Chicago Growth Partners, MPM BioImpact, SightLine Partners.
Will Endoluminal Solutions Inc. IPO soon?
No public IPO plans have been announced for Endoluminal Solutions Inc..
How can I track Endoluminal Solutions Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Endoluminal Solutions Inc.'s shares on secondary markets.